ArticleNeoplasia (New York, N.Y.)2023

Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer.

Abdol-Hossein Rezaeian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.